Maravai Lifesciences Holdings Inc (MRVI)

Mar 05, 2026

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Mar 05, 2026

Mar 05, 2026

Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat

Mar 05, 2026

Mar 05, 2026

Royce & Associates LP Has $5.06 Million Stock Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat

Mar 05, 2026

Mar 05, 2026

First Eagle Investment Management LLC Makes New Investment in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat

Mar 05, 2026

Mar 02, 2026

MRVI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 02, 2026

Feb 28, 2026

Maravai Lifesciences Charts Early Turnaround in 2025 - TipRanks

Feb 28, 2026

Feb 28, 2026

Maravai LifeSciences (NASDAQ:MRVI) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat

Feb 28, 2026

Feb 27, 2026

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Assessing a Potential 14% Upside in the Biotechnology Sector - DirectorsTalk Interviews

Feb 27, 2026

Feb 26, 2026

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap UpStill a Buy? - MarketBeat

Feb 26, 2026

Feb 26, 2026

Is Maravai LifeSciences Holdings Inc.’s ROE strong enoughMarket Growth Report & Fast Exit and Entry Trade Guides - mfd.ru

Feb 26, 2026

Feb 26, 2026

Maravai Q4 2025 slides: return to positive EBITDA on cost cuts - Investing.com Nigeria

Feb 26, 2026

Feb 26, 2026

Maravai LifeSciences Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

Maravai LifeSciences Holdings Inc (MRVI) Q4 2025 Earnings Call Highlights: Surpassing Revenue ... By GuruFocus - Investing.com Canada

Feb 26, 2026

Feb 26, 2026

Maravai LifeSciences Holdings (MRVI) Posts US$130.8m TTM Loss Challenging Margin Recovery Narratives - Sahm

Feb 26, 2026

Feb 26, 2026

Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results - BioSpace

Feb 26, 2026

Feb 26, 2026

Maravai LifeSciences Q4 Earnings Call Highlights - MarketBeat

Feb 26, 2026

Feb 26, 2026

Maravai LifeSciences Holdings, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:MRVI) 2026-02-26 - Seeking Alpha

Feb 26, 2026

Feb 26, 2026

Maravai LifeSciences Holdings Inc (MRVI) Q4 2025 Earnings Call H - GuruFocus

Feb 26, 2026

Feb 25, 2026

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Feb 25, 2026

Feb 25, 2026

Maravai Q4 2025 slides: return to positive EBITDA on cost cuts By Investing.com - Investing.com South Africa

Feb 25, 2026

Feb 25, 2026

Earnings call transcript: Maravai Lifesciences Q4 2025 beats EPS forecast, stock jumps 4.5% - Investing.com Canada

Feb 25, 2026

Feb 25, 2026

MRVI: 2025 saw revenue beat, margin recovery, and strong 2026 growth and profitability guidance - TradingView

Feb 25, 2026

Feb 25, 2026

Maravai LifeSciences Holdings Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Feb 25, 2026

Feb 25, 2026

Maravai LifeSciences (NASDAQ:MRVI) Issues Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat

Feb 25, 2026

Feb 25, 2026

Maravai LifeSciences Holdings, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com

Feb 25, 2026

Feb 25, 2026

MRVI Projects FY26 Adjusted EBITDA Between $18M and $20M - GuruFocus

Feb 25, 2026

Feb 25, 2026

Maravai LifeSciences (MRVI) Surpasses Revenue Expectations in Q4 - GuruFocus

Feb 25, 2026

Feb 25, 2026

Maravai LifeSciences (NASDAQ: MRVI) posts 2025 loss but targets 2026 EBITDA rebound - Stock Titan

Feb 25, 2026

Feb 25, 2026

Maravai LifeSciences Q4 2025 Earnings Call Transcript - MarketBeat

Feb 25, 2026

Feb 25, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Feb 25, 2026

Feb 22, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Feb 22, 2026

Feb 21, 2026

What are Maravai LifeSciences Holdings Inc.’s growth levers2025 Geopolitical Influence & Weekly High Return Stock Opportunities - mfd.ru

Feb 21, 2026

Feb 21, 2026

Maravai LifeSciences Holdings, Inc. $MRVI Shares Bought by Monaco Asset Management SAM - MarketBeat

Feb 21, 2026

Feb 20, 2026

Value Recap: What is the PEG ratio of Maravai LifeSciences Holdings IncEarnings Overview Report & Daily Entry Point Alerts - baoquankhu1.vn

Feb 20, 2026

Feb 20, 2026

Maravai LifeSciences Holdings (MRVI) Investor Outlook: Navigating a 27.55% Upside Amidst Challenging Metrics - DirectorsTalk Interviews

Feb 20, 2026

Feb 19, 2026

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Feb 19, 2026

Feb 19, 2026

Stock Traders Purchase High Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat

Feb 19, 2026

Feb 18, 2026

Maravai LifeSciences (MRVI) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Feb 18, 2026

Feb 17, 2026

12 West Capital (NASDAQ: MRVI) discloses 6.2% beneficial stake in Maravai - Stock Titan

Feb 17, 2026

Feb 16, 2026

Is There An Opportunity With Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 34% Undervaluation? - Yahoo Finance

Feb 16, 2026

Feb 15, 2026

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of "Hold" by Brokerages - MarketBeat

Feb 15, 2026

Feb 14, 2026

MRVI Should I Buy - Intellectia AI

Feb 14, 2026

Feb 13, 2026

Market Moves: Will REFI face regulatory challengesWeekly Investment Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn

Feb 13, 2026

Feb 13, 2026

Investor group (NASDAQ: MRVI) reports 7.23% Maravai LifeSciences stake - Stock Titan

Feb 13, 2026

Feb 12, 2026

Options Flow: Will Cohen Company Inc face regulatory challengesQuarterly Trade Review & Smart Investment Allocation Tips - baoquankhu1.vn

Feb 12, 2026

Feb 12, 2026

Gainers Report: Is Maravai LifeSciences Holdings Incs ROE strong enough2025 Buyback Activity & Smart Swing Trading Techniques - baoquankhu1.vn

Feb 12, 2026

Feb 09, 2026

Maravai to Announce Q4 and Full Year 2025 Results - Intellectia AI

Feb 09, 2026

Feb 09, 2026

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 - Business Wire

Feb 09, 2026

Feb 09, 2026

What MACD trends signal for Maravai LifeSciences Holdings Inc. (MAR) stockQuarterly Trade Review & Reliable Breakout Stock Forecasts - mfd.ru

Feb 09, 2026

Feb 08, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire

Feb 08, 2026

Feb 06, 2026

Growth Report: Is Tourmaline Bio Inc a speculative investmentProduct Launch & AI Powered Market Entry Strategies - baoquankhu1.vn

Feb 06, 2026

Feb 05, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect - ACCESS Newswire

Feb 05, 2026

Feb 05, 2026

Maravai LifeSciences Target of Unusually High Options Trading (NASDAQ:MRVI) - MarketBeat

Feb 05, 2026

Feb 04, 2026

Volume Report: How does Maravai LifeSciences Holdings Inc score in quality rankings2025 Market WrapUp & Weekly Watchlist for Hot Stocks - baoquankhu1.vn

Feb 04, 2026

Feb 01, 2026

Tejara Capital Ltd Has $7.04 Million Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat

Feb 01, 2026

Jan 31, 2026

Stock Analysis: Is Amylyx Pharmaceuticals Inc stock a buy or sell2025 Technical Overview & Consistent Profit Alerts - baoquankhu1.vn

Jan 31, 2026